MA32142B1 - Forme cristalline de dérivés de phénylamino pyrimidine - Google Patents
Forme cristalline de dérivés de phénylamino pyrimidineInfo
- Publication number
- MA32142B1 MA32142B1 MA33147A MA33147A MA32142B1 MA 32142 B1 MA32142 B1 MA 32142B1 MA 33147 A MA33147 A MA 33147A MA 33147 A MA33147 A MA 33147A MA 32142 B1 MA32142 B1 MA 32142B1
- Authority
- MA
- Morocco
- Prior art keywords
- crystalline form
- phenyl amino
- pyrimidine derivatives
- amino pyrimidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne une forme particulière de (3,5-bis trifluorométhyl)-n-[4- méthyl-3-(4-pyridin-3yl-pyrirnidin-2ylamino)-phényl]-benzamide (formule i), ses procédés de préparation, des compositions pharmaceutiques contenant cette forme cristalline et leur utilisation comme agent tumoral chez l'homme. Le composé de la formule (i) est également connu sous le nom de an- 019.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/042,247 US8067422B2 (en) | 2008-03-04 | 2008-03-04 | Crystal form of phenylamino pyrimidine derivatives |
US12/042,235 US8183253B2 (en) | 2004-09-09 | 2008-03-04 | Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
PCT/IB2009/005421 WO2009109867A2 (fr) | 2008-03-04 | 2009-03-02 | Forme cristalline de dérivés de phénylamino pyrimidine |
Publications (1)
Publication Number | Publication Date |
---|---|
MA32142B1 true MA32142B1 (fr) | 2011-03-01 |
Family
ID=40802116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA33147A MA32142B1 (fr) | 2008-03-04 | 2010-09-03 | Forme cristalline de dérivés de phénylamino pyrimidine |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2265599B1 (fr) |
JP (1) | JP2011513380A (fr) |
KR (1) | KR20100126464A (fr) |
CN (1) | CN102015681B (fr) |
AP (1) | AP2651A (fr) |
AR (1) | AR070783A1 (fr) |
AU (1) | AU2009220856B2 (fr) |
CA (1) | CA2716413A1 (fr) |
CO (1) | CO6300946A2 (fr) |
EA (1) | EA019223B1 (fr) |
GE (1) | GEP20135882B (fr) |
IL (1) | IL207750A0 (fr) |
MA (1) | MA32142B1 (fr) |
MX (1) | MX2010009401A (fr) |
MY (2) | MY183331A (fr) |
NZ (1) | NZ587518A (fr) |
WO (1) | WO2009109867A2 (fr) |
ZA (1) | ZA201005957B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011049625A1 (fr) | 2009-10-20 | 2011-04-28 | Mansour Samadpour | Procédé de criblage d'aflatoxine dans des produits |
KR102012398B1 (ko) | 2009-11-05 | 2019-08-20 | 리젠 파마슈티컬스 소시에떼 아노님 | 신규한 벤조피란 키나제 조절제 |
GB2488788B (en) * | 2011-03-07 | 2013-07-10 | Natco Pharma Ltd | Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response |
US10451897B2 (en) | 2011-03-18 | 2019-10-22 | Johnson & Johnson Vision Care, Inc. | Components with multiple energization elements for biomedical devices |
US9110310B2 (en) | 2011-03-18 | 2015-08-18 | Johnson & Johnson Vision Care, Inc. | Multiple energization elements in stacked integrated component devices |
MX365160B (es) | 2011-05-04 | 2019-05-24 | Rhizen Pharmaceuticals Sa | Compuestos novedosos como moduladores de proteína cinasas. |
DK3260455T3 (da) | 2012-07-04 | 2019-06-11 | Rhizen Pharmaceuticals S A | Selektive pi3k delta-hæmmere |
US10361405B2 (en) | 2014-08-21 | 2019-07-23 | Johnson & Johnson Vision Care, Inc. | Biomedical energization elements with polymer electrolytes |
US9793536B2 (en) | 2014-08-21 | 2017-10-17 | Johnson & Johnson Vision Care, Inc. | Pellet form cathode for use in a biocompatible battery |
US10381687B2 (en) | 2014-08-21 | 2019-08-13 | Johnson & Johnson Vision Care, Inc. | Methods of forming biocompatible rechargable energization elements for biomedical devices |
US9715130B2 (en) | 2014-08-21 | 2017-07-25 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form separators for biocompatible energization elements for biomedical devices |
US9599842B2 (en) | 2014-08-21 | 2017-03-21 | Johnson & Johnson Vision Care, Inc. | Device and methods for sealing and encapsulation for biocompatible energization elements |
US10361404B2 (en) | 2014-08-21 | 2019-07-23 | Johnson & Johnson Vision Care, Inc. | Anodes for use in biocompatible energization elements |
US10627651B2 (en) | 2014-08-21 | 2020-04-21 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form biocompatible energization primary elements for biomedical devices with electroless sealing layers |
US9383593B2 (en) | 2014-08-21 | 2016-07-05 | Johnson & Johnson Vision Care, Inc. | Methods to form biocompatible energization elements for biomedical devices comprising laminates and placed separators |
US9941547B2 (en) | 2014-08-21 | 2018-04-10 | Johnson & Johnson Vision Care, Inc. | Biomedical energization elements with polymer electrolytes and cavity structures |
US10345620B2 (en) | 2016-02-18 | 2019-07-09 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form biocompatible energization elements incorporating fuel cells for biomedical devices |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2591321C (fr) * | 2004-09-09 | 2013-09-24 | Natco Pharma Limited | Derives de phenylaminopyrimidine comme inhibiteurs de la kinase bcr-abl |
-
2009
- 2009-03-02 MY MYPI2010004153A patent/MY183331A/en unknown
- 2009-03-02 GE GEAP200911960A patent/GEP20135882B/en unknown
- 2009-03-02 AP AP2010005390A patent/AP2651A/xx active
- 2009-03-02 MX MX2010009401A patent/MX2010009401A/es active IP Right Grant
- 2009-03-02 NZ NZ587518A patent/NZ587518A/xx not_active IP Right Cessation
- 2009-03-02 JP JP2010549212A patent/JP2011513380A/ja active Pending
- 2009-03-02 EP EP09716746.4A patent/EP2265599B1/fr not_active Not-in-force
- 2009-03-02 CN CN2009801160310A patent/CN102015681B/zh not_active Expired - Fee Related
- 2009-03-02 EA EA201071019A patent/EA019223B1/ru not_active IP Right Cessation
- 2009-03-02 WO PCT/IB2009/005421 patent/WO2009109867A2/fr active Application Filing
- 2009-03-02 CA CA2716413A patent/CA2716413A1/fr not_active Abandoned
- 2009-03-02 MY MYPI2014002513A patent/MY175373A/en unknown
- 2009-03-02 AU AU2009220856A patent/AU2009220856B2/en not_active Ceased
- 2009-03-02 KR KR1020107021992A patent/KR20100126464A/ko not_active Application Discontinuation
- 2009-03-04 AR ARP090100757A patent/AR070783A1/es not_active Application Discontinuation
-
2010
- 2010-08-20 ZA ZA2010/05957A patent/ZA201005957B/en unknown
- 2010-08-23 IL IL207750A patent/IL207750A0/en unknown
- 2010-09-02 CO CO10108728A patent/CO6300946A2/es not_active Application Discontinuation
- 2010-09-03 MA MA33147A patent/MA32142B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
GEP20135882B (en) | 2013-07-25 |
JP2011513380A (ja) | 2011-04-28 |
MY175373A (en) | 2020-06-23 |
AR070783A1 (es) | 2010-05-05 |
CO6300946A2 (es) | 2011-07-21 |
CN102015681A (zh) | 2011-04-13 |
ZA201005957B (en) | 2011-10-26 |
CN102015681B (zh) | 2013-08-28 |
EP2265599B1 (fr) | 2013-11-20 |
IL207750A0 (en) | 2010-12-30 |
CA2716413A1 (fr) | 2009-09-11 |
NZ587518A (en) | 2012-09-28 |
AU2009220856A1 (en) | 2009-09-11 |
EA019223B1 (ru) | 2014-02-28 |
AP2010005390A0 (en) | 2010-10-31 |
EP2265599A2 (fr) | 2010-12-29 |
AU2009220856A2 (en) | 2010-09-16 |
AU2009220856B2 (en) | 2012-07-26 |
AP2651A (en) | 2013-04-25 |
MY183331A (en) | 2021-02-18 |
MX2010009401A (es) | 2010-09-24 |
WO2009109867A2 (fr) | 2009-09-11 |
WO2009109867A3 (fr) | 2009-12-17 |
KR20100126464A (ko) | 2010-12-01 |
EA201071019A1 (ru) | 2011-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA32142B1 (fr) | Forme cristalline de dérivés de phénylamino pyrimidine | |
SMT201600267B (it) | Inibitori di syk imidazopirazinici | |
SMT201700036B (it) | Composti e composizioni come inibitori di protein chinasi | |
SMT201600275B (it) | Composti eterociclici utili come inibitori di pdk1 | |
DK2262793T3 (da) | Krystallinske former af nilotinib-hci | |
MA32551B1 (fr) | Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires | |
SMT201600085B (it) | Piperidin-4-il azetidin derivati come inibitori di jak1 | |
HK1212973A1 (zh) | 壞死性雕亡的小分子抑制劑 | |
CR20130470A (es) | INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA | |
CR20120641A (es) | Compuestos macrocìclicos como inhibidores de quinasa trk | |
DK2364308T3 (da) | Pyrazinforbindelser som inhibitorer af Phosphodiesterase 10 | |
CR20130369A (es) | Novedosos derivados heterocíclicos | |
MA32487B1 (fr) | Nouvelles pyridine-2-ones et pyridazine-3-ones substituees | |
CR20120121A (es) | Compuestos de benzoxazepina como inhibidores de la pi3k y métodos de uso | |
DK2389382T3 (da) | Aminoheterocykliske forbindelser anvendt som pde9-inhibitorer | |
BR112012006686A2 (pt) | composto amida substituído | |
EA201190227A1 (ru) | Оксазолзамещенные индазолы в качестве ингибиторов pi3-киназ | |
DK2448938T3 (da) | Pyrimidinoner som pi3k-inhibitorer | |
DK2310046T3 (da) | Hidtil ukendte adjuvanssammensætninger | |
CY1109766T1 (el) | Παραγωγα αζαπεπτιδιου ως αναστολεις πρωτεασης hiv | |
CY1113716T1 (el) | Νεα μεθοδος συνθεσης της αγομελατινης | |
CR20130419A (es) | Derivados heterocíclicos de amina | |
HK1156306A1 (en) | Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases hif--4- | |
SMT201500157B (it) | Pirazolilaminopiridine come inibitori di fak | |
CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη |